Instil Bio looking like a 10-15 percent move to thee upsideTIL looks like it is getting ready to make a 10-15% move to the upside.
As you can see by the chart, its easy to mange with stops.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−11.56 USD
−156.09 M USD
0.00 USD
3.05 M
About Instil Bio, Inc.
Sector
Industry
CEO
Bronson Crouch
Website
Headquarters
Dallas
Founded
2018
FIGI
BBG00ZGYN521
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TIL is 20.17 USD — it has decreased by −2.10% in the past 24 hours. Watch Instil Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Instil Bio, Inc. stocks are traded under the ticker TIL.
TIL stock has risen by 4.91% compared to the previous week, the month change is a −17.94% fall, over the last year Instil Bio, Inc. has showed a 168.87% increase.
We've gathered analysts' opinions on Instil Bio, Inc. future price: according to them, TIL price has a max estimate of 180.00 USD and a min estimate of 110.00 USD. Watch TIL chart and read a more detailed Instil Bio, Inc. stock forecast: see what analysts think of Instil Bio, Inc. and suggest that you do with its stocks.
TIL stock is 8.15% volatile and has beta coefficient of 12.92. Track Instil Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Instil Bio, Inc. there?
Today Instil Bio, Inc. has the market capitalization of 139.65 M, it has increased by 11.68% over the last week.
Yes, you can track Instil Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Instil Bio, Inc. is going to release the next earnings report on Mar 10, 2025. Keep track of upcoming events with our Earnings Calendar.
TIL earnings for the last quarter are −3.54 USD per share, whereas the estimation was −2.11 USD resulting in a −67.97% surprise. The estimated earnings for the next quarter are −3.01 USD per share. See more details about Instil Bio, Inc. earnings.
Instil Bio, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 1.90 M USD. In the next quarter, revenue is expected to reach 0.00 USD.
TIL net income for the last quarter is −23.02 M USD, while the quarter before that showed −14.92 M USD of net income which accounts for −54.33% change. Track more Instil Bio, Inc. financial stats to get the full picture.
No, TIL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 49.00 employees. See our rating of the largest employees — is Instil Bio, Inc. on this list?
Like other stocks, TIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Instil Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Instil Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Instil Bio, Inc. stock shows the sell signal. See more of Instil Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.